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Abstract
HSAF was isolated from Lysobacter enzymogenes, a bacterium used in the biological control of
fungal diseases of plants. Structurally, it is a tetramic acid-containing macrolactam fused to a
tricyclic system. HSAF exhibits a novel mode of action by disrupting sphingolipids important to
the polarized growth of filamentous fungi. Here, we described the HSAF biosynthetic gene cluster
which contains only a single-module polyketide synthase-nonribosomal peptide synthetase (PKS/
NRPS), although the biosynthesis of HSAF apparently requires two separate polyketide chains
that are linked together by one amino acid (ornithine) via two amide bonds. Flanking the PKS/
NRPS are six genes, encoding a cascade of four tightly clustered redox enzymes on one side and a
sterol desaturase/fatty acid hydroxylase and a ferredoxin reductase on the other side. The genetic
data demonstrate that the four redox genes, in addition to the PKS/NRPS gene and the sterol
desaturase/fatty acid hydroxylase gene, are required for HSAF production. The biochemical data
show that the adenylation domain of the NRPS specifically activated L-ornithine and the four-
domain NRPS was able to catalyze the formation of a tetramic acid-containing product from acyl-
S-ACP and ornithinyl-S-NRPS. These results reveal a previously unrecognized biosynthetic
mechanism for hybrid PK/NRP in prokaryotic organisms.
We have previously isolated a novel antifungal compound (HSAF, 1) from Lysobacter
enzymogenes C3, which is a bacterium used for the biological control of fungal diseases of
plants.1 HSAF exhibits potent inhibitory activities against a wide range of fungal species
and shows a novel mode of action by disrupting the biosynthesis of fungal sphingolipids.2
Sphingolipids represent an attractive new target for the development of novel antifungal
drugs because their structure in fungal cells is distinct from that in mammalian cells.3 HSAF
is a tetramic acid (2,4-pyrrolidinedione)-containing macrolactam (Figure 1).1 Tetramic acid
is the key structural feature for many bioactive heterocycles that exhibit a wide range of
biological activities including antibiotic and anticancer activities.4 The macrolactam
structure is also found in many bioactive natural products. HSAF combines these two
structural features. In addition, it contains a 5,5,6-tricyclic system fused to the macrolactam.
Such structural features are shared by a group of natural products (2-7) that were isolated
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from marine invertebrates and/or associated microorganisms (Figure 1). No biosynthetic
studies on these marine metabolites have been reported. Previously, we reported four HSAF
biosynthetic genes, including a hybrid polyketide synthase-nonribosomal peptide synthetase
(PKS/NRPS). Since then, we have been searching for additional PKS genes around this
PKS/NRPS locus, because the biosynthesis of HSAF apparently requires two separate
polyketide chains. We now provide the complete sequence of the gene cluster based on the
genome sequences. The most striking finding is that only a single PKS/NRPS is present in
the gene cluster. We have also expressed the NRPS module and demonstrated in vitro that it
specifically activates L-ornithine and catalyzes the formation of a tetramate product.
In L. enzymogenes C3, we previously identified three genes downstream to the PKS/NRPS.
Gene disruption data showed that only the gene encoding sterol desaturase/fatty acid
hydroxylase is required for HSAF production.1 Because biosynthetic genes for PK/NRP in
microorganisms are almost always clustered together, we searched the region upstream to
the PKS/NRPS, where we found four genes (OX1 to OX4, EF028635.2) that encode a
cascade of NADP/FAD-dependent oxidoreductases. OX1, 2, and 3 are similar to each other,
while OX4 is distinct (Figure 1). The OX genes appear to form an operon with the PKS/
NRPS, because they are either translationally coupled or have only a small intergenic region
in between. To test their relevance to HSAF biosynthesis, we disrupted each of the OX
genes. The disruption mutants of OX1, 2, and 3 did not produce HSAF, whereas the
disruption mutants of OX4 produced a small amount of a metabolite with a [M+H]+ of
511.2789, which is two mass units smaller than HSAF and coincident with the mass of
maltophilin, a putative precursor of HSAF (Figure S1). To eliminate the potential polar
effect caused by insertion of the conjugal vector, we then generated four in-frame deletion
mutants by deleting a small sequence (6-11 residues) at the highly conserved active sites of
the OXs (Figure S2-S5). The results showed that the deletion mutants of OX1, 2, and 3 did
not produce HSAF while the OX4 deletion mutants still produced the same putative
precursor. Together, the results show that the OX genes are required for the biosynthesis of
the final product.
The Liu group has been using L. enzymogenes OH11 as a biocontrol agent for plant fungal
diseases in China.5 We recently completed the draft genome sequence of strain OH11. The
results showed that strain OH11 has all the HSAF genes found in strain C3. Within the
HSAF genes (20280 bp), the two strains have a 96% identity. At the amino acid sequence
level, the individual ORFs have an identity of 98-99%. With the genome sequence, we could
search for “extra PKS” genes juxtaposed to the HSAF locus. Surprisingly, no such gene is
present. The center of the gene cluster is the hybrid PKS/NRPS. Flanking the PKS/NRPS
are genes encoding six redox enzymes, arginase, putative transporters and receptors/
regulators (Figure 1B and S6). Beyond the 55 kb region shown in Figure 1B, we only found
genes encoding rRNA, ribosome proteins, tRNA and DNA repairing proteins, which
apparently are not related to HSAF biosynthesis. The HSAF biosynthetic gene cluster
contains only a single-module PKS/NRPS, a cascade of redox enzymes, and several putative
transporter/regulators. Recently, Clardy and coworkers also observed similar results in gene
clusters mined from a number of Streptomyces genomes.6 They found that this type of
single-module hybrid PKS/NRPS is conserved among phylogenetically diverse bacterial
species.
To test whether the single NRPS module could accept two separate acyl chains to produce
the characteristic tetramic acid-containing product, we conducted a series of in vitro
experiments. We first expressed the adenylation domain of the PKS-NRPS in E. coli and
used the purified 66.4 kDa protein (Figure S7) for an ATP-PPi exchange assay. Among the
16 amino acids tested, the A-domain specifically activates L-ornithine and, to a lesser
extent, L-lysine (Figure S7). We then tested the in vitro activity of the entire NRPS module
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(Figure 2). The 4-domain NRPS (C-A-PCP-TE) was expressed in E. coli as a His6-tagged
protein with an expected size of 148.6 kDa (Figure 2B). The promiscuous 4’-
phosphopantetheine transferase Svp was used to prepare stearoyl-S-ACP and holo-NRPS.7
The holo-NRPS was then loaded with L-ornithine in the presence of ATP, producing the
ornithinyl-SNRPS substrate (Figure 2A). When stearoyl-S-ACP and ornithinyl-S-NRPS
were incubated together, we detected a [M+H]+ ion of 647.6080 in the reactions (Figure
2C), which is consistent with the predicted mass of the product 8. This molecular ion was
not present in the control reaction without the NRPS protein. The putative tetramic acid
structure was correlated with an authentic sample prepared as illustrated in Scheme 1 (also
see Scheme SI-1). The boroxazolidinone adduct of L-ornithine (9) was selectively acylated
at the terminal amino group with octadecanoyl chloride to furnish a monoamide.8
Deprotection of the boroxazolidinone with ethylenediamine, followed by reaction with
thionyl chloride in methanol furnished methyl ester 10. Conversion of the amino acid ester
to the tetramic acid was accomplished through a modification of a published approach.9
Condensation of the amino ester with 2-benzyloxycarbonyloctacadecanoic acid 11, prepared
in two steps from dibenzyl malonate, furnished the α,δ-bisamide 12 as an inseparable ~1:1
mixture of diastereomers. Reaction with excess sodium hydride resulted in tandem Claisen
condensation and deacylation to furnish tetramic acid 8 as a 1:1 mixture of epimers at C3 of
the 3,5-dioxopyrrolidine. The retention time and mass spectra of the synthetic tetramic acid
sample matched exactly the enzymatically synthesized material (Figure 2C).
These results show that the two amide functionalities in HSAF are formed between two acyl
chains and ornithine, one at the α-amino and the other at the δ-amino group of ornithine. The
results also suggest that the HSAF NRPS module is able to accept two polyketide acyl-S-
ACPs, making two amide bonds on the same amino acid via two Claisen-condensation
reactions and forming the tetramic acid ring via a Dieckmann-type reaction.
Hybrid PKS/NRPS have been found in gene clusters for several tetramic acid-containing
natural products, such as tenellin, aspyridone A, equisetin, and cyclopiazonic acid.10 All
these PKS/NRPS contain a reductase (R) domain in the end of the enzyme, which is
responsible for the cyclization of tetramic acid and the release of the hybrid PK/NRP chain
via a Dieckmann-type condensation. In HSAF PKS/NRPS, the TE domain is most likely the
candidate for this activity. In spite of the functional similarity, the R domain's substrate is a
thioester attached to the PCP domain, whereas the TE domain's substrate is an oxoester
attached to TE itself.11 Another interesting question in HSAF biosynthesis is if the C
domain catalyzes the formation of both amide bonds or if the TE domain is also involved.
We are currently working on the enzymes to answer this question.
Clardy and coworkers found that all HSAF-type gene clusters contain a central PKS/NRPS
flanked by genes encoding a cascade of redox enzymes.6 In HSAF, we found that all four
OX genes, in addition to the genes for PKS/NRPS and sterol desaturase/fatty acid
hydroxylase, are required for HSAF biosynthesis. These genes could be involved in the
formation of the 5,5,6-tricyclic system and the conversion of maltophilin to HSAF.
Although the disruption of the ferredoxin reductase gene and arginase gene did not eliminate
HSAF production in the mutants, these genes may play a pathway-specific role (as a
reducing partner for the redox enzymes, or the synthesis of ornithine from arginine via the
urea cycle). The MFS transporter and the TonB-dependent outer membrane receptor could
play a role in resistance and regulation.
The iterative use of a single-module PKS/NRPS is common in fungi but is rare in bacteria.12
Only a few bacterial modular PKSs were reported to act iteratively.13 Here, our results show
that HSAF PKS/NRPS presents one of the first two examples where a single-module PKS
assembles two separate polyketide chains that are linked together via two amide bonds on
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the same amino acid and are subsequently folded/cyclized into a complex scaffold, probably
by a cascade of redox enzymes. These results open a new area of biosynthetic research to
study hybrid PK/NRP products with a very unusual scaffold and interesting biological
activities.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
(A) Structure of HSAF and related tetramic acid-containing macrolactams. The compounds
are divided into two groups based on their possible biosynthetic mechanisms: the
hexaketide-ornithine-hexaketide group and the pentaketide-ornithine-hexaketide group. Both
groups can have a 17-membered macrolactam fused to a tricyclic system or a 21-membered
macrolactam fused to a bicyclic system. (B) Map of the HSAF gene cluster (EF028635.2).
The ORFs in the blocked region are annotated here; the annotation of the rest of the ORFs is
included in Figure S6.
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Figure 2.
In vitro synthesis of a tetramic acid-containing product (8) using the purified HSAF NRPS.
(A) Schematic illustration of the reactions. The acyl-S-ACP substrate was prepared by
incubating ACP and stearoyl-CoA with Svp, and Orn-S-NRPS was prepared by incubating
NRPS and CoA with Svp, followed by addition of L-ornithine and ATP. (B) SDS-PAGE
showing the expression and purification of the 4-domain NRPS. The expected size of the
NRPS is 148.6 kDa. Lane-1, markers; lane-2, purified NRPS; lane-3, soluble fraction of
protein extracts; lane-4, total protein extracts upon IPTG induction; lane-5, total protein
extracts before IPTG induction. (C) LC-MS detection of the expected product 8. The first is
a control reaction without the NRPS, the second is a complete reaction to show the
production of the expected product with a [M+H]+ of 647.6080, and the third is the
chemically synthesized standard 8 (mixture of diastereomers).
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Scheme 1.
Preparation of tetramic acid 8.
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1. General Materials and Methods  
Chemicals used in this study were purchased from Fisher Scientific or Sigma. All 
oligonucleotide primers for PCR were synthesized by Integrated DNA Technologies (IDT, 
Coralville, IA). Plasmid preparation and DNA extraction were carried out with Qiagen kits 
(Valencia, CA), and all other DNA manipulations were carried out according to standard 
methods. Escherichia coli strain XL Blue was used as the host for general plasmid DNA 
propagation, and the cloning vector was pANT841. Vectors pET28a or pQE60 were used for 
protein expression in E. coli BL21 (DE3) or SG13009 (pREP4), respectively. 
 
2. Generation of four OX gene disruption mutants 
To construct the gene disruption vectors, an internal fragment was amplified from each of the 
four OX genes using the primer pairs listed below. 
OX1For 5′-GCC GCT GGA GAA CTG GAA GG-3′  
OX1Rev 5′-GCTGAA GTA GGT GAC GTG GAT GA-3′ 
OX2For 5′-GCT GTA CCC GTT CCT GAC GC-3′ 
OX2Rev 5′-TTC TTC CTC GCT GAG CAG ATA AGT-3′ 
OX3For  5′-TCC CGG TGC TGC CGT TCT A-3′ 
OX3Rev 5′-TGC GGT TCG GCG ATG GT-3′ 
OX4For  5′-AAG CTC GAC CTG CGC CAC T-3′ 
OX4Rev 5′-TTC TGC TCG GTG AAC CAC TCC-3′ 
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The sizes of the PCR fragments for OX1, 2, 3, and 4 were 712, 622, 328 and 539 bp, 
respectively. The fragments were cloned into pGEM-T vector and their identity was confirmed 
by DNA sequencing. Each of the fragments was then transferred to the conjugal vector 
pJQ200SK as an ApaI/SpeI fragment to produce pJQ200SK-OX1-4. Each of the pJQ200SK-OX 
was transformed into E. coli S17-1, which was mated with Lysobacter enzymogenes C3 for 
conjugal transfer of the constructs. The positive colonies grown on LB plates containing 
gentamicin (20 µg/ml) were picked up and inoculated into liquid cultures containing gentamicin. 
Genomic DNA was prepared from each of the cultures, and diagnostic PCR were performed to 
identify mutants that resulted from a homologous recombination at the respective OX genes. The 
following primer pairs were used for these experiments. 
MOX1For 5′-GGG CAA CAA CGC CAA CC-3′ 
MOX1Rev 5′-CCC TCA TCA GTG CCA ACA TAG-3′ 
MOX2For 5′-CTG CAT CGA ATG GCT GAT C-3′ 
MOX2Rev 5′-TCT TTA TAG TCC TGT CGG GTT T-3′ 
MOX3For 5′-CCC CTA CTT CAA CGC CAT CC-3′ 
MOX3Rev 5′-CAC CCT CAT CAG TGC CAA C-3′ 
MOX4For 5′-ACC TTC CCG ATG GTG TTCC C-3′ 
MOX4Rev 5′-ACG ACC GAG CGT AGC GAG T-3′ 
In each of the primer pairs, the forward primer will anneal to the corresponding OX gene at a 
location that is outside the PCR fragment used in the gene disruption constructs, and the reverse 
primer will anneal to a location within pJQ200SK vector. The expected size of the PCR product 
from OX1 mutants was 1345 bp, which will release two fragments of 1000 and 345 bp upon 
ApaI digestion. The expected size of the PCR product from OX2 mutants was 1566 bp, which 
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will release two fragments of 916 and 650 bp upon ApaI digestion. The expected size of the PCR 
product from OX3 mutants was 839 bp, which will release two fragments of 492 and 347 bp 
upon ApaI digestion. The expected size of the PCR product from OX4 mutants was 1072 bp, 
which will release two fragments of 611 and 461 bp upon ApaI digestion. As shown in Figure 
S1A, the diagnostic PCR and ApaI digestion produced the expected results, and all of mutants 
were real OX gene disrupted mutants. 
A 
 
B 
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Figure S1. (A) Diagnostic PCR and restriction enzyme digestion of the PCR products to 
verify the OX mutants. (B) HPLC analysis of the metabolites produced by the OX gene 
disrupted mutants. The putative maltophilin peak produced by the OX4 mutant and the 
HSAF peak produced by the wild type strain are indicated with an arrow. 
 
To analyze the metabolites, the mutants were grown in 1/10 TSB medium containing 
gentamicin (20 µg/ml). The procedure for metabolite extraction and analysis was the same as 
described previously.1 The results showed that the gene disruption mutants of OX1, OX2, and 
OX3 did not produce any detectable HSAF, whereas the OX4 mutants produced a small amount 
of a metabolite with a [M+H]+ of 511, which is two mass units smaller than HSAF (Figure S1B). 
 
3. Generation of four OX gene in-frame deletion mutants  
To eliminate the potential polar effect caused by insertion of the conjugal vector, we also 
generated in-frame deletion mutants for each of the four OX genes. To construct the OX3 in-
frame deletion vector, primer extension PCR reactions were performed to generate a 593-bp 
fragment of OX3 gene with an EcoRI site introduced to replace a 27-bp sequence within the gene. 
This would delete 9 amino acid residues (LVEDDRAVG) within a sequence motif that is highly 
conserved among the FAD-dependent oxidoreductases. The following primers were used for 
these experiments. 
P1-OX3-For   
5′-ATT CTA GAT TCC TCC CCT ACT TCA ACG CCA TCC G-3′  
P2-OX3-Rv-Fusion   
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5′-GCC CGT CGC TCA GGC GGA GAA TTC GAT CTC CTC GAC TTT CGC-3′  
P1'-OX3-For-Fusion   
5′-GCG AAA GTC GAG GAG ATC GAA TTC TCC GCC TGA GCG ACG GGC-3′  
P2'-OX3-Rv   
5′-ATC TCG AGA CTG CAC GTT GAT GCT CGG GTG GCG-3′  
Genomic DNA of L. enzymogenes C3 was used as template and the enzyme was Phusion HF 
polymerase (New England BioLabs). The PCR program was as follows: denaturation at 98 ºC for 
5 min, followed by 35 cycles of 98 ºC for 30 sec, 65 ºC for 30 sec and 72 ºC for 40 sec. To 
amplify the complete OX3 in-frame deletion cassette, the upstream homologous region (left arm, 
LA) was amplified with P1-OX3-For/P2-OX3-Rv-Fusion and the downstream homologous 
region (right arm, RA) was amplified with P1'-OX3-For-Fusion/P2-OX3-Rv. Purified PCR 
products from the first step served both as template and the primers for extension PCR that runs 
11 cycles of amplification under the same condition in a 20 µl PCR system. Primers P1-OX3-
For/P2’-OX3-Rv were then added to further amplify the fusion PCR products for 20 cycles. The 
fusion product was subjected to 1% agarose gel analysis. The product with the desired size was 
purified from the gel and served as the template to amplify the fusion PCR product for 35 cycles 
in a 40 µl PCR system. The fragment was then cloned into the conjugal vector pJQ200SK as an 
XhoI/XbaI fragment to produce pJQ200SK-OX3 (Figure S2A and B).  
To construct the OX4 gene in-frame deletion vector, a 525-bp fragment was amplified from 
OX4 gene, with an EcoRI site introduced to replace a 33-bp sequence within the gene. This 
would delete 11 amino acid residues (PFRPGDLVQGF) within a sequence motif that is highly 
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conserved among the Zn-dependent alcohol dehydrogenases. The following primers pairs were 
used for these experiments.  
P1-OX4-For   
5′-ATA CTA GTG ACC GCA AGC ACA TGA AGA CCG AAC G-3′  
P2-OX4-Rv-Fusion 
5′-AGG TGC GTG CGC CAG CCG CCG AAT TCC GCG TTC GGG CCG GCA TCG A-3′ 
P1'-OX4-For-Fusion 
5′-TCG ATG CCG GCC CGA ACG CGG AAT TCG GCG GCT GGC GCA CGC ACC T-
3′  
P2'-OX4-Rv  
5′-ATC TCG AGA ACC AGG GTG CCG ATC ATG CCC GAG G-3′ 
To amplify the complete OX4 in-frame deletion cassette, the left arm was amplified with P1-
OX4-For/P2-OX4-Rv-Fusion and the right arm was amplified with P1'-OX4-For-Fusion/ P2-
OX4-Rv. The same PCR program as OX3 was used. The fragment was then cloned to the 
conjugal vector pJQ200SK as an XhoI/SpeI fragment to produce pJQ200SK-OX4 (Figure S3A 
and B).  
To conjugally transfer pJQ200SK-OX4 and pJQ200SK-OX3 into L. enzymogenes strain C3, 
the procedure was identical to the previously described.1  To screen the single crossover mutants, 
the genomic DNA was prepared from 1/10 TSB cultures of the individual colonies. For the OX3-
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deletion mutants, primers P1 (5′-AAG TAG GTG GCG TAG ACG-3′) and P2 (5′-CCC TCA 
TCA GTG CCA ACA TAG-3′) were used to screen the left arm single crossover mutants  
(Figure S2C). A 1002-bp fragment was expected from the positive colonies. The OX4-deletion 
mutants were identified similarly using primers N1 (5′-TTC TGC TCG GTG AAC CAC TCC-3′) 
and N2 (5′-CCC TCA TCA GTG CCA ACA TAG-3′) (Figure S3C). A 1281-bp fragment was 
expected from the positive colonies. For both PCR reactions, the genomic DNA of wild type L. 
enzymogenes served as the template for a negative control. No product with expected size was 
observed in the negative control. 
The single colonies identified from single crossover were subjected to liquid cultures 
containing 5% (W/V) sucrose to select for the loss of the vector through a second homologous 
recombination. The single crossover mutants were grown in 1/10 tryptic soy broth (TSB) 
medium for 14 hours. Then the individual cultures were re-inoculated into 1/10 TSB (with 1:100 
ratio) containing 5% sucrose and 25 µg/ml kanamycin medium. Aliquots (50 µl) were taken out 
every 3 hours from this liquid culture and spread onto 1/10 TSA plates (5% sucrose, 25 µg/ml 
kanamycin). Single colonies were picked up from the plates and continued to grow in 1/10 TSB 
(5% sucrose, 25 µg/ml kanamycin) liquid medium for another 2-5 days.   
To confirm the double crossover mutants, the genomic DNA was prepared from 1/10 TSB 
cultures of the individual single colonies. OX3 double crossover mutants were screened using 
primers P1 (5′-AAG TAG GTG GCG TAG ACG-3′) and P3 (5′-TAT CCC TTC CTC AAG 
CCG-3′), which amplify a 702-bp fragment from the positive mutants. An EcoRI digestion of 
this fragment yielded two products of 349-bp and 352-bp, as expected (Figure S2D and S4A, 
lane 1 and 2). The EcoRI digestion also gave a band around 700 bp, in addition to the expected 
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bands. A careful examination of the gel indicated that the PCR using primers P1/P3 gave two 
very close bands around 700 bp, one being the expected 702-bp product (which was cut into 349-
bp and 352-bp by EcoRI) and the other likely being an unspecific product, probably amplified 
from a homologous sequence such as OX1 and OX2 (with ~70%/80% of identity/similarity). To 
confirm this, we further digested the PCR product using another enzyme, SmaI, which is a 
naturally present site in OX3 gene. Upon SmaI digestion, the 702-bp PCR product was cut into 
508 bp and 195 bp, as expected, whereas the around 700-bp band remained uncut (Figure S4A, 
lane 5 and 6). Together, the results confirmed the OX3 mutant.    
OX4 double crossover mutants were screened using primers N1 (5′-TTC TGC TCG GTG 
AAC CAC TCC-3′) and N3 (5′-TTC CGC AAC TCG CCA CGA CC-3′), which amplify a 902-
bp fragment from the positive mutants. An EcoRI digestion of this fragment yielded two 
products of 625-bp and 277-bp, as expected (Figure S3D and S4A, lane-3 and 4).  
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 Figure S2. OX3 gene in-frame deletion scheme. The deletion cassette was cloned into 
conjugal vector pJQ200SK at the XhoI/XbaI sites. Red bar represents the EcoRI site introduced 
into the host genome to replace a 27-bp sequence of the original gene. Primers P1/P2 were 
used for screening single crossover mutants, and primers P1/P3 were used for double crossover 
mutant screening. 
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Figure S3. OX4 gene in-frame deletion scheme. The deletion cassette was cloned into conjugal 
vector pJQ200SK at the XhoI/SpeI sites. Red bar represents the EcoRI site introduced into the 
host genome to replace a 33-bp sequence of the original gene. Primers N1/N2 were used for 
screening single crossover mutants, and primers N1/N3 were used for double crossover mutant 
screening. 
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Figure S4. (A) Screening of the OX3 and OX4 in-frame deletion mutants by PCR. Lane 1, 
undigested PCR product from OX3-double crossover mutant (expecting 702 bp); lane 2, EcoRI 
digestion of OX3 mutant PCR product (expecting 349 bp and 352 bp); lane 3, undigested PCR 
product from OX4-double crossover mutant (expecting 902 bp); lane 4, EcoRI digestion of OX4 
mutant PCR product (expecting 625 bp and 277 bp); lane M, 100 bp DNA ladder; lane 5, SmaI 
digestion of OX3 mutant PCR product (expected 508 bp and 195 bp); lane 6, undigested PCR 
product from OX3 mutant (expected 702 bp).  
(B) Screening of the OX1 in-frame deletion mutants by PCR. Lane 1, EcoRI digestion of wild 
type OX1 PCR product (expecting 1198 and 446 bp); lane 2, EcoRI digestion of OX1 mutant 
PCR product (expecting 736 bp, 462 bp and 446 bp); lane M, 100 bp DNA ladder.  
(C) Screening of the OX2 in-frame deletion mutants by PCR. lane 3, EcoRI digestion of wild 
type OX2 PCR product (expecting 536 bp); lane 4, EcoRI digestion of the OX2 overlapping PCR 
product (the initial PCR product used to construct the gene deletion vector, as a positive control 
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here, expecting 161 bp and 375 bp); lane 5, EcoRI digestion of OX2 mutant PCR product 
(expecting 161 bp and 375 bp); lane M, 100 bp DNA ladder. 
 
To construct the OX1 in-frame deletion vector, a 543-bp fragment of OX1 gene with an 
EcoRI site introduced to replace a 27-bp sequence within the gene. This would replace 9 amino 
acid residues (LVEDGRAVG) within a sequence motif that is highly conserved among the FAD-
dependent oxidoreductases. The procedure for generating OX1 in-frame deletion was identical to 
that for OX3. The following primers were used for these experiments. 
OX1-Up-Forw- XhoI: 
5′-AGA CTC GAG AAG CTA GCC ACG CTG C-3′ 
OX1-Up-Revs-EcoRI: 
5′-CGT CTC GAA GAC GAA TTC CAG CTC TAC CAC CCG GTC GAC GCG GGT-3′ 
OX1-Down-forw-EcoRI:  
5′-GTA GAG CTG GAA TTC GTC TTC GAG ACG GTA CGG CTC AAG AAC GGC-3′  
OX1-Down-Rev-BamHI: 
5′- ACT GGA TCC CGA CTC GCC GGC CGG CA-3′ 
The following primers were used to screen for OX1 single crossover mutants. A 1083-bp 
fragment was produced from the positive colonies. 
P1-OX1 5′-TAA GGA TCC GCC GGC ATG GCC ACC G -3′ 
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P2-OX1 5′-ACC ATG ATT ACG CCA AGC-3′  
The OX1 double crossover mutants were screened using primers P1-OX1 and P3-OX1, 
which amplified a 1644-bp fragment from the positive mutants. An EcoRI digestion of this 
fragment yielded three products of 736-bp, 462-bp and 446-bp, as expected (Figure S4B). 
P3-OX1 5′-TCA CTC GAG TCA GGC GGC CGG AAG C-3′ 
 
To construct the OX2 gene in-frame deletion vector, a 536-bp fragment was amplified from 
OX2 gene, with an EcoRI site introduced to replace an 18-bp sequence within the gene. This 
would replace 6 amino acid residues (GGGVGG) within a sequence motif that is highly 
conserved among the FAD-dependent oxidoreductases. The procedure for generating OX2 in-
frame deletion was identical to that for OX3. The following primers pairs were used for these 
experiments. 
OX2-UP-Forw-XhoI:  
5′-CCA CTC GAG CCC GAC CAT GCC GCA C-3′   
OX2-Up-Revs-EcoRI:  
5′-TGC GCC GAA TTC GCC AGC GAT GAC GAT CAC CCG CGG CGT-3′ 
OX2-Down-Forw-EcoRI:  
5′-GCT GGC GAA TTC GGC GCA CTG TCC ACC GGC GTC TAC GGC-3′ 
OX2-Down-Revs-BamHI: 
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5′-CTT GGA TCC GCG GCG CAG GTC GGC-3’ 
The following primers were used to screen for OX2 single crossover mutants. A 657-bp 
fragment was produced from the positive colonies. 
N1-OX2 5′-ACC ACG AGG ACC CGA CCA TGC-3′  
N2-OX2 5′-ACC ATG ATT ACG CCA AGC-3′  
The OX2 double crossover mutants were screened using primers N3-OX2 and N4-OX2, 
which amplified a 536-bp fragment from the positive mutants. An EcoRI digestion of this 
fragment yielded two products of 161-bp and 375-bp, as expected (Figure S4C).  
N3-OX2 5′- CCACTCGAGCCCGACCATGCCGCAC -3′ 
N4-OX2 5′- CTTGGATCCGCGGCGCAGGTCGGC -3′  
 
To analyze the metabolites, the mutants were grown in 1/10 TSB medium containing 
gentamicin (20 µg/ml). The procedure for metabolite extraction and analysis was the same as 
described previously (Figure S5).1 Metabolites were collected from HPLC and analyzed by high-
resolution electronspray ionization mass spectrometry to detect if any HSAF or analog was 
produced in the mutants. The results showed that the in-frame gene deletion mutants of OX1, 
OX2, and OX3 did not produce HSAF, whereas the OX4 mutant gave a broad peak on HPLC at 
the retention time of ~22 minute (Figure S5A). MS analysis of the main metabolite showed a 
[M+H]+ of 511.2789 (- 3.7 ppm), which is two mass units smaller than HSAF and coincident 
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with the mass of maltophilin (calculated m/z 511.2808), a putative precursor of HSAF (Figure 
S5B). 
A. 
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Figure S5. (A) HPLC analysis of the metabolites produced by the four OX gene in-frame 
deletion mutants. The putative maltophilin peak produced by the OX4 mutant and the HSAF 
peak produced by the wild type strain are indicated with an arrow. (B) MS analysis of the peak at 
~22 minute in the OX4 mutant in (A). 
 
4. Mapping of the HSAF locus 
We used the 20280-bp HSAF gene cluster (EF028635.2) identified from Lysobacter 
enzymogenes C3 to search the genome sequences of L. enzymogenes OH11. All the genes 
previously identified from strain C3 were also present in strain OH11. In addition, we analyzed 
the regions upstream (~44 kb) and downstream (~66 kb) to the HSAF locus. Immediately 
upstream to the OX4 gene was a MFS transporter (ORF1) and a 4.3 kb region that did not 
contain any obvious ORF (Figure S6). Three ORFs (ORF-A, B, and C) were identified further 
upstream to the 4.3 kb gap region. In the downstream region, eleven ORFs (ORF-D through N) 
were identified, and the majority of these ORFs appear to encode genes related to DNA repairing 
and cellular communications and transportations. These ORFs are listed in Figure S6. 
 
 
Figure S6. Annotation of the flanking regions of the HSAF biosynthetic genes. 
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5. Adenylation domain expression and ATP-PPi exchange assays 
To construct the expression vector, a 1731 bp fragment was amplified by PCR using Pfu 
DNA polymerase and the cosmid COS8-1 as template, which contains part of the HSAF gene 
cluster. The forward primer was 5′-TTA GGA TCC ACC CGG CTG CCG GCG CAG-3′, and 
the reverse primer was 5′-CCG CTC GAG TCA CAG CAA CTG CTT CCA GTG-3′. The PCR 
fragment was digested with BamHI and XhoI and cloned into pANT841 at the same sites. The 
construct was sequenced, and the result showed that the A-domain sequence was correct. The A-
domain was released from pANT841 as a BamHI/XhoI fragment and cloned into expression 
vector pET28a. To express the A-domain, the pET28a construct was introduced into E. coli 
BL21 (DE3). Single colonies were inoculated in 3 ml of liquid LB medium containing 
kanamycin (50 µg/ml) and incubated in a shaker (250 rpm) at 37oC overnight. The overnight 
culture was added to 50 ml fresh LB medium and incubated in a shaker (250 rpm) at 37oC until 
the cell density (OD600) reached 0.6. To induce the expression of the A domain, IPTG (0.1 mM) 
was added to the culture, and the cells were allowed to grow at the same conditions for another 3 
h. To prepare the soluble fraction, the cells were harvested and resuspended in 2 ml of PBS 
buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). The cell 
suspension was added with lysozyme (1 mg/ml) and sonicated five times on ice. The soluble 
fraction of protein extracts was loaded onto a Ni-NTA column which was previously calibrated 
with PBS buffer containing 10 mM imidazole. The column was washed three times with the 
buffer containing 20 mM imidazole, and the His6-tagged protein was eluted twice with 200 µl of 
PBS buffer containing 250 mM imidazole (Figure S7). The fractions containing pure A-domain 
were collected and dialyzed against PBS buffer containing 15 % glycerol.  
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Figure S7. (A) Expression and purification of the adenylation domain of the hybrid 
PKS/NRPS. Lane-1, total proteins upon IPTG induction; lane-2, the soluble fraction; lane-3, 
the purified A-domain. (B) ATP-PPi exchange assay for the adenylation domain. 
 
To test the activity of the A-domain, the ATP-PPi exchange assay was used (Figure S7).2 
Sixteen amino acids were tested as substrates. The reactions contained one amino acid (1 mM), 
A-domain protein (180 nM), 32P-PPi (0.6 µCi, 80.47 Ci/mmol, PerkinElmer Life and Analytical 
Sciences, Downers Grove, IL) in sodium phosphate buffer (50 mM, pH 7.8) containing EDTA 
(0.1 mM), MgCl2 (1 mM) and ATP (1 mM), in a final volume of 100 µl. ATP and the 32P-PPi 
were added at the end, and the reactions were incubated 15 min at 30oC. 
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6. Whole NRPS module expression 
To express the four-domain NRPS module of HSAF hybrid PKS/NRPS, a 3966 bp fragment 
was amplified by PCR using Pfu DNA polymerase and the cosmid COS8-1 as template. The 
forward primer was C-NcoI-Fw, 5′-TAA TCC ATG GAG CAG TTG CAT GCC GGC CTG 
GTC GAG-3′, and the reverse primer was TE-BamHI-Rv, 5′-TTA GGA TCC GGC GAC ATG 
GCC CGT CTC CCC-3′. The resulting PCR product was initially ligated into pANT841. After 
the insert was verified by restriction enzyme digestions and DNA sequencing, it was transferred 
to pQE60. This expression construct was then introduced into E. coli SG13009 (pREP4). Single 
colonies were inoculated in LB supplemented with 50 µg/ml ampicillin and  25 µg/ml 
kanamycin and were grown to OD600 = 0.7 at 37°C. The cultures were cooled for 20 min at 4 °C, 
and IPTG (0.5 mM) was added to the cultures, which were allowed to grow for an additional 14 
h at 25 °C. The cells were harvested and resuspended in 20 mM PBS, pH 7.8, containing 5 mM 
imidazole, 500 mM NaCl, 1 mg/mL lysozyme, 1 mM PMSF, and 0.5% Triton X-100. The 
mixtures were incubated on ice for 30 min, followed by sonication and centrifugation. The 
soluble fraction was loaded onto a Ni-NTA column (Qiagen), and the C-His6-tagged NRPS 
protein (148.6 kDa) was purified by using an imidazole step-gradient as described by the 
manufacturer’s protocol. The purity of the protein was analyzed by SDS-PAGE, and the 
fractions containing purified protein were pooled, concentrated, and dialyzed against 20 mM 
PBS, 50 mM NaCl, pH 7.8, 15% glycerol. Finally the protein solution was frozen in liquid 
nitrogen and stored at -80 °C until use. 
 
7. In vitro assay for the activity of the NRPS module 
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To test the activity of the NRPS module, the first step was to prepare an acyl-ACP substrate 
and holo-NRPS. The acyl-ACP substrate was obtained by incubating stearoyl-CoA (0.67 mM) 
and Fum1p-ACP (49 µM) 3 with Svp (5.6 µM) 4 in a 50 µl reaction containing Tris-HCl (100 
mM, pH 8.0). The reason to use Fum1p-ACP was that the ACP of hybrid PKS-NRPS for HSAF 
biosynthesis could not be expressed heterologously. We tried both the T5 promoter-based 
expression system (such as pQE60) and the T7 promoter-based expression system (such as 
pET28a), and expressed it under different conditions (temperatures and IPTG concentrations). 
However, this ACP appeared to be refractory for heterologous expression.  
The holo-NRPS was obtained by incubating C-A-PCP-TE (3 µM) and CoA (0.83 mM) wih 
Svp (5.6 µM) in a 60 µl reaction containing Tris-HCl (100 mM, pH 8.0), MgCl2 (10 mM), and 
TCEP (0.5 mM). Both reactions were incubated at 37 ℃ for 2 h. Finally, these two reaction 
mixtures were combined into a tube containing a 40 µl solution containing L-Orn (1.5 mM), 
ATP (3 mM), Tris-HCl (100 mM, pH 8.0), MgCl2 (10 mM), NaCl (50 mM), EDTA (0.1 mM), 
and TCEP (0.5 mM). A reaction without C-A-PCP-TE protein served as the control. After 
continual incubation for 50 hr at 37 ℃, the reactions were stopped by adding 150 µl of 0.2 mM 
TCA in methanol and were frozen at -20 °C for 30 min. The mixtures were centrifuged at 13,200 
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rpm for 20 min in a desktop Eppendorf centrifuge, and the supernatants were transferred to new 
tubes. The solutions were dried in a Speed-Vac, and the residues in the tubes were re-dissolved 
in 150 µl methanol. The methanol solutions were centrifuged, transferred to new tubes, and dried 
again. Finally, the products were re-dissolved in 20 µl methanol (containing 5 mM ammonium 
acetate) and analyzed by LC Q-TOF (Waters; Micromass UK, Beverly, MA, USA) equipped 
with Shimadzu system controller SCL-10A and two pumps LC-10AT and LC-10AD. The LC-
MS column was Alltima C18LL (5 u, 1.0 mm × 250 mm). Solvent A was H2O containing 5 mM 
ammonium acetate; Solvent B was MeOH containing 5 mM ammonium acetate. The flow rate 
was 50 µl/min, with a binary gradient system (0-5 min, 30% B; 5-20 min, 30% B to 100% B 
gradient; 20-30 min, 100% B; 30-40 min, 100% B to 30% B gradient; 40-45 min, 30% B). 
 
8. Chemical synthesis of tetramic acid 8 
Overview of tetramic acid synthesis: An authentic sample of the proposed tetramic acid 
structure was prepared as illustrated in Scheme SI-1. The boroxazolidinone adduct of L-ornithine 
(9)1 was selectively acylated at the terminal amino group with octadecanoyl chloride to furnish a 
monoamide. Deprotection of the boroxazolidinone with ethylenediamine,5 followed by reaction 
with thionyl chloride in methanol furnished methyl ester 10.  Conversion of the amino acid ester 
to the tetramic acid was accomplished through a Dieckmann reaction6,7 based upon a 
modification of a published approach.8 Condensation of the amino ester with 2-
benzyloxycarbonyl-octacadecanoic acid 11, prepared in two steps from dibenzyl malonate, 
furnished the bisamide 12 as an inseparable ~1:1 mixture of diastereomers.8 Reaction with 
excess sodium hydride resulted in tandem Claisen condensation5 and deacylation9 to furnish 
tetramic acid 8 as a 1:1 mixture of epimers at C3 of the 3,5-dioxopyrrolidine. 
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Scheme SI-1. Preparation of the tetramic acid 8 
General Synthesis and Characterization Procedures: All reagents and solvents were used as 
supplied commercially, except CH2Cl2 and THF, which were distilled from CaH2, and 
Na/benzophenone, respectively. Melting points are uncorrected. Unless noted, NMR spectra 
were acquired at 400 MHz (1H) or 100 MHz (13C) in CDCl3. IR spectra were recorded as neat 
films on a ZrSe crystal with selected absorbances reported in cm-1. Mass spectroscopy was 
conducted at the Nebraska Center for Mass Spectrometry. 
L-ornithine monohydrochloride, 9-borabicyclononane complex (9) 
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9 
Compound 9 was prepared by the procedure of Fields from L-ornithine monohydrochloride.5 
The product, which retained solvent, was carried on into the next procedure without purification. 
N5-octadecanoyl-L-ornithine, 9-borabicyclononane complex 
O
O
N
H
NH2B
C17H35
O
 
 
To a solution of compound 9 (3.06 g, 10 mmol) in THF 100 ml was added Et3N (6.0 ml, 40 
mmol) and stearoyl chloride (4.30 g, 12 mmol). The reaction mixture was stirred at rt for 6 h and 
then concentrated  in vacuo. The residue was dissolved in 200 ml water, and the aqueous layer 
was extracted with CH2Cl2 (100 ml × 3). The combined organic layers were dried over 
anhydrous Na2SO4 and filtered. The residue obtained upon concentration was purified by 
chromatography (CH2Cl2/MeOH, 95:5) to afford the octadecanoic amide as a  white solid (4.40 g, 
86%), Rf 0.6 (CH2Cl2/MeOH 90/10), Mp 69-70 ° C. [α]D = -13.8 (CHCl3, c = 1.0).  IR 3344, 
3128, 3110, 2920, 2850, 1692, 1681, 1544, 1376, 1273, 963, 878, 722 cm-1; 1H NMR: δ6.60 (t, 
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J= 6.4 Hz, 1H), 5.92 (t, J= 8.8 Hz, 1H), 5.01 (t, J= 9.6 Hz, 1H), 3.78 (t, J= 6.3 Hz, 1H), 3.28 (m, 
1H), 3.20 (m, 1H), 2.16 (t, J= 7.1 Hz, 2H), 2.05 (m, 1H), 1.94-1.12 (45H), 0.88 (t, J= 6.9 Hz, 3H), 
0.57 (d, J= 10.8 Hz, 2H); 13C NMR: 175.0, 174.3, 55.1, 38.7, 36.7, 31.9, 31.7, 31.4, 31.3, 31.2, 
29.73, 29.67, 29.58, 29.44, 29.41, 29.36, 28.1, 26.4, 25.9, 24.5, 24.0, 22.7, 14.1; HRMS (m/z) 
calcd for C31H59BN2NaO3 [M+Na]+ : 541.4516; found: 541.4514 (-0.4 ppm).  
 L-ornithine, N5-octadecanoylamide, methyl ester (10) 
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Ethylene diamine (1.7 ml, 25 mmol) was added to a solution of N5-octadecanoyl-L-ornithine, 9-
borabicyclononane complex  (2.80 g, 5.5 mmol) in THF (15 ml).5  The solution was  heated to 
just below boiling for 1 min, and then cooled and filtered.  The precipitate was washed with THF 
(25 ml × 3), and dried in vacuo to give a white solid, which was suspended in MeOH (100 ml). 
SOCl2  (1.9 ml, 25 mmol) was added dropwise, and the reaction mixture was refluxed for 2 h. 
After removal of solvent in vacuo, the residue was dissolved in water 100 ml. The solution was 
adjusted to pH 10 with sat. aq. K2CO3, and then extracted with CH2Cl2 (50 ml × 3). The 
combined organic layers were dried over anhydrous Na2SO4, and the filtrate concentrated in 
vacuo to afford 10 as a white solid (2.26 g, 92%), which was used without further purification. Rf 
0.3 (CH2Cl2/MeOH/NEt3 90/10/1),   Mp 59-61 ° C; [α]D = -7.1 (CHCl3, c = 1.0). IR 3318, 2916, 
2848, 1741, 1646, 1553, 1232, 718 cm-1; 1H NMR: 6.01 (t, J= 5.4 Hz, 1H), 3.70 (s, 3H), 3.44 (t, 
J= 6.9 Hz, 1H), 3.24 (m, 2H), 2.13 (t, J = 7.2 Hz, 2H), 1.60 (m, 4H), 1.30-1.21 (32H), 0.86 (t, J = 
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6.9 Hz, 3H); Traces of an impurity could be seen in the NMR as signals at 3.65 ppm and 2.28 
ppm;  13C NMR: 176.2, 173.2, 54.0, 52.1, 39.0, 26.8, 32.1, 31.9, 29.67, 29.63, 29.5, 29.37, 29.33, 
25.9, 25.8, 22.7, 14.1; HRMS (m/z) calcd for C24H48N2NaO3 [M+Na]+  (note:  we experienced 
difficulties in achieving adequate dissolution of this sample in a sodium acetate buffer): 
435.3563; found: 435.3562 (-0.2 ppm). 
 
2-(Benzyloxycarbonyl)octadecanoic acid, benzyl ester  
BnO
O O
OBn
C16H33  
Dibenzylmalonate (2.84 g, 10 mmol) was added to a stirred solution of NaH (0.24 g, 10 mmol) 
in dry THF (10 ml) and dry DMF (10 ml) and the mixture was stirred at rt for 1 h. 1-
Iodohexadecane (3.52 g, 10 mmol) was then added and the reaction mixture was refluxed for 3 h. 
The cooled reaction mixture was concentrated in vacuo and the residue added to sat. aq. NH4Cl 
(100 ml), and the aqueous layer was extracted by Et2O (100 ml × 3). The combined organic 
layers were dried over anhydrous Na2SO4 and the filtrate was concentrated in vacuo. Flash 
chromatography (Hexane/EtOAc, 95:5) afforded the diester as a low-melting white solid (4.67 g, 
92%). Rf 0.3 (Hexane/EtOAc 95/5). Mp 41-42 ° C; IR 2914, 2848, 1752, 1728, 1463, 1455, 
1184,1143, 724, 669 cm-1; 1H NMR: δ7.34 (m, 10H), 5.19 (s, 4H), 3.48 (t, J= 7.5 Hz, 1H), 1.97 
(dd, J= 7.1 Hz, 13.8 Hz, 2H), 1.38-1.21 (28H), 0.93 (t, J= 7.0 Hz, 3H); 13C NMR:δ169.3, 135.5, 
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128.6, 128.3, 128.2, 67.0, 52.1, 32.0, 29.73, 29.69, 29.64, 29.5, 29.4, 29.3, 29.2, 28.8, 27.2, 22.7, 
14.2 ; HRMS (m/z) calcd for C33H48NaO4 [M+Na]+: 531.3450; found: 531.3447 (-0.6 ppm).  
 
2-(Benzyloxycarbonyl)octadecanoic acid  was prepared by a modification of a procedure 
reported for malonic acid monobenzyl ester.6 
BnO
O O
OH
C16H33
 
To a suspension of KOH  (0.28 g, 5 mmol) in benzyl alcohol (5.0 ml) was added gradually to a 
solution of the diester (2.62 g, 5 mmol) in benzyl alcohol (25 ml). The reaction mixture was 
stirred at rt for 24 h, and the solvent was then removed in vacuo. The residue was dissolved in 
water (100 ml) and the solution acidified to pH 2 with 3 M HCl. The aqueous layer was extracted 
with CH2Cl2 (100 ml × 3) and then combined organic layers were dried over anhydrous Na2SO4.  
The filtrate was concentrated in vacuo to afford a solid which was recrystallized from heptane to 
afford the monoester as a white solid (1.69 g, 81%): Rf 0.6 (Hexane/EtOAc/AcOH 20/20/1). Mp 
46-48 °C; IR 2916, 2848, 1745, 1696, 1470, 1259, 1231, 936, 730, 718 cm-1; 1H NMR: δ10.08 
(br, 1H), 7.40 (m, 5H), 5.23 (s, 2H), 3.47 (t, J= 7.4 Hz, 1H), 1.97 (m, 2H), 1.40-1.24 (28H), 0.92 
(t, J= 6.7 Hz, 3H); 13C NMR: 175.2, 169.3, 135,3, 128.6, 128.4, 128.2, 67.3, 51.7, 32.0, 29.73, 
29.69, 29.63, 29.5, 29.39, 29.31, 29.2, 28.9, 27.2, 22.7, 14.1; HRMS (m/z) calcd for C26H42NaO4  
[M+Na]+: 441.2981; found: 441.2966 (-3.4 ppm).  
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L-ornithine, N5-octadecanoylamide-N2-(2-benzyloxycarbonyl)octadecanoylamide (12) 
MeO
O
N
H
HN
C17H35
O
O
C16H33
COOBn
 
12 
To a solution of compound 10 (0.20 g, 0.48 mmol) in CH2Cl2 (20 ml) was sequentially added 
N,N'-dicyclohexylcarbodiimide (0.12 g, 0.58 mmol) and monoester 11 (0.20 g, 0.48 mmol). The 
reaction mixture was refluxed for 4 h, cooled to rt, and then filtered. The filtrate was dried over 
anhydrous Na2SO4, and then refiltered before being concentrated in vacuo. Flash 
chromatography (Hexane/EtOAc, 60:40) afforded 12 as a white solid (0.28 g, 72%), Rf 0.4 
(Hexane/EtOAc 50/50). Mp 100-101 °C; IR 3304, 2916, 2849, 1736, 1639, 1545, 1272, 1236, 
720, 695 cm-1; 1H NMR: δ7.37 (m, 5H), 7.17 (d, J= 7.5 Hz, 0.5H), 7.13 (d, J= 7.8 Hz, 0.5H, 
isomer), 5.72 (t, J= 6.3 Hz, 1H), 5.20 (m, 2H), 4.58 (m, 1H), 3.75 (s, 1.5H), 3.74(s, 1.5H, isomer), 
3.31 (dd, J= 7.1, 14.3 Hz, 1H), 3.24 (m, 2H), 2.15 (m, 2H), 1.86 (m, 4H), 1.65-1.25 (60H), 0.89 
(t, J= 6.9 Hz, 6H); 13C NMR 173.38, 173.31(isomer), 172.3, 172.2(isomer), 171.7, 171.4(isomer), 
168.4, 168.3(isomer), 135.32, 135.29(isomer), 128.6, 128.5, 128.4, 67.2, 52.95, 52.86(isomer), 
52.51, 52.48(isomer), 51.93, 51.91(isomer), 38.6, 26.8, 31.9, 30.9, 30.5, 29.71, 29.66, 29.5, 
29.40, 29.37, 29.22, 29.17, 27.25, 27.21, 25.8, 25.4, 22.7, 14.1 ; HRMS (m/z calcd for 
C50H88N2NaO6 ) [M+Na]+: 835.6540; found: 835.6533 (-0.8 ppm).  
3-Hexadecyl-5-(3-aminopropyl)-pyrrolidine-2,4-one, octadecanoyl amide (8) was prepared 
using a modification of a procedure reported for other tetramic acids.8 
 28 
NH
O
O
C16H33 N
H
O
C17H35
 
8 
To a 100ml RB flast was added NaH (60% dispersion in mineral oil, 13 mg, 0.37 mmol). The 
slurry was washed by pentane, after which  compound 12 (81 mg, 0.10 mmol) was added in THF 
(10 ml). The reaction mixture was refluxed for 6 h and then cooled to rt. After removal of solvent 
in vacuo, the residue was suspended in water (15 ml) and the solution acidified to pH 2 with 3 M 
HCl. The combined CH2Cl2 extracts (10 ml × 3) were dried over anhydrous Na2SO4 and the 
filtrate concentrated in vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5) afforded 8 as a 
white solid (48 mg, 74%). Rf 0.5 (CH2Cl2/MeOH 90/10). Mp 108-109 °C. IR 2916, 2848, 1686, 
1639, 1467, 720 cm-1; 1H NMR: δ6.94 (d, J= 3.9 Hz, 0.5H), 6.88 (d, J= 8.4 Hz, 0.5H, isomer), 
5.60 (t, J= 5.4 Hz, 1H), 4.01 (t, J= 6.7 Hz, 0.5H), 3.92 (t, J= 5.4 Hz, 0.5H, isomer), 3.29 (m, 2H), 
2.83 (t, J= 5.8 Hz, 0.5H), 2.76 (t, J= 5.8 Hz, 0.5H, isomer), 2.17 (t, J= 7.6 Hz, 2H),1.91-1.56(8H), 
1.47-1.20 (56H), 0.90 (t, J= 6.6 Hz, 6H); 13C NMR (150 MHz): 211.1, 210.7 (isomer), 174.2, 
173.9 (isomer), 173.6, 62.3, 61.9(isomer), 49.7, 49.1(isomer), 38.5, 36.8, 31.9, 29.71, 29.67, 
29.58, 29.52, 29.37, 29.34, 29.31, 28.7, 27.2, 26.6, 26.5, 26.20, 25.9, 25.8, 25.5, 22.7, 14.1; 
HRMS (m/z) calcd for C41H78N2NaO3+ [M+Na]+: 669.5910; found: 669.5935 (3.7 ppm). 
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